- Home
- KIM vs FMS Comparison
KIM vs FMS Comparison
Compare KIM & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KIM
- FMS
- Stock Information
- Founded
- KIM 1958
- FMS 1996
- Country
- KIM United States
- FMS Germany
- Employees
- KIM N/A
- FMS N/A
- Industry
- KIM Real Estate Investment Trusts
- FMS Misc Health and Biotechnology Services
- Sector
- KIM Real Estate
- FMS Health Care
- Exchange
- KIM Nasdaq
- FMS Nasdaq
- Market Cap
- KIM 14.4B
- FMS 13.8B
- IPO Year
- KIM 1991
- FMS 1996
- Fundamental
- Price
- KIM $21.00
- FMS $26.93
- Analyst Decision
- KIM Buy
- FMS Hold
- Analyst Count
- KIM 15
- FMS 1
- Target Price
- KIM $24.50
- FMS $30.00
- AVG Volume (30 Days)
- KIM 3.9M
- FMS 448.2K
- Earning Date
- KIM 07-31-2025
- FMS 07-29-2025
- Dividend Yield
- KIM 4.76%
- FMS 2.92%
- EPS Growth
- KIM 46.99
- FMS 27.83
- EPS
- KIM 0.76
- FMS 2.28
- Revenue
- KIM $2,069,884,000.00
- FMS $21,068,786,202.00
- Revenue This Year
- KIM $5.01
- FMS $2.74
- Revenue Next Year
- KIM $3.04
- FMS $3.60
- P/E Ratio
- KIM $27.66
- FMS $23.22
- Revenue Growth
- KIM 12.23
- FMS 0.10
- 52 Week Low
- KIM $17.93
- FMS $17.93
- 52 Week High
- KIM $25.83
- FMS $30.46
- Technical
- Relative Strength Index (RSI)
- KIM 50.92
- FMS 39.22
- Support Level
- KIM $20.69
- FMS $28.41
- Resistance Level
- KIM $21.14
- FMS $28.96
- Average True Range (ATR)
- KIM 0.32
- FMS 0.39
- MACD
- KIM -0.03
- FMS -0.30
- Stochastic Oscillator
- KIM 44.58
- FMS 26.46
About KIM Kimco Realty Corporation (HC)
One of the oldest real estate investment trusts in the United States, Kimco Realty owns interests in 569 shopping centers throughout major markets in the US, representing roughly 87 million square feet.
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three quarters of sales while the balance is generated from medical technology products that enable dialysis treatments.